The size of Myanmar’s pharmaceutical market is USD 400 million and the country imports 85-90 per cent of its pharma products.

Venus Remedies, after receiving the marketing authorization from Myanmar, are looking to capture a sizeable chunk of the antibiotics market with Elores.

Elores, an antibiotic, is effective against serious multidrug-resistant hospitalacquired infections.

Venus Remedies, headquartered at Panchkula in Haryana, has three manufacturing units -Panchkula, Baddi (HP) and Werne (Germany) and 11 overseas marketing offices, including a presence in the US and Germany. The registration procedure of this product is in advanced stages in 13 European Union member-nations and 15 other countries, including South Korea, South Africa and Saudi Arabia.